ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q3SCImago #21,924Diamond OA

Journal of Inborn Errors of Metabolism and Screening

Identifier (ISSN):2326-4098(Print)/2326-4594(Online)
•
Publisher:SciELO
Clarivate JCR Index Advisory: Not Indexed in Latest JCR
Clarivate Impact Factor (IF 2024)
N/A
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓

Impact Factor Trend

Clarivate IF trend for Journal of Inborn Errors of Metabolism and Screening

WoS Q1
000002023
Annual Impact Factor Metric
Current (2023):0
Scopus SJR & RankScopus Q3
0.2
#21,924

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
16

16 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation RateN/A
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessDiamond OA
0articles/year
0% Gold OA•0% Original Research

Aims & Scope

The Journal of Inborn Errors of Metabolism and Screening (JIEMS) is an online peer-reviewed open access journal devoted to publishing clinical and experimental research in inherited metabolic disorders and screening, for health professionals and scientists. Original research articles published in JIEMS range from basic findings that have implications for disease pathogenesis and therapy, passing through diagnosis and screening of metabolic diseases and genetic conditions, and therapy development and outcomes as well. Original articles, reviews on specific topics, brief communications and case reports are welcome. JIEMS aims to become a key resource for geneticists, genetic counselors, biochemists, molecular biologists, reproductive medicine researchers, obstetricians/gynecologists, neonatologists, pediatricians, pathologists and other health professionals interested in inborn errors of metabolism and screening.

Topics Covered (Recognized by AI)
Medicine91%Biology75.9%Internal medicine69.8%Chemistry67.8%Biochemistry63.8%Pathology51.8%Genetics48.2%Disease36.7%Endocrinology28.6%Pediatrics27.6%Physics26.6%Psychology23.1%Gene23.1%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF—
Articles / Year9
Total Citations0
2025
IF—
Articles / Year13
Total Citations8
2024
IF—
Articles / Year9
Total Citations2
2023
IF0
Articles / Year12
Total Citations18
2022
IF—
Articles / Year11
Total Citations24

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #21,924Scopus Q3SCImago Profile
Scopus Coverage:2015-2025
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q3
0.2

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
0.45

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,434 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations16
3-Year Documents33
Citable Documents32

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate59.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pediatrics, Perinatology and Child HealthQ3
Endocrinology, Diabetes and MetabolismQ4
Genetics (clinical)Q4
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
Updating
Minor Category (Specific Field):
Updating
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Inborn Errors of Metabolism and Screening (ISSN: 2326-4098) is a peer-reviewed international scholarly journal across multidisciplinary scientific domains, published by SciELO in Brazil. The periodical holds tracked under Web of Science (SCIE) in quartile Q1, a Scopus SJR indicator of 0.200 (Q3), an H-index of 16.

The journal enforces rigorous peer evaluation with an annual output of approximately 0 scientific articles. In terms of accessibility and author fees, it operates under the Diamond OA model with an estimated APC of $2,434 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Diamond OA
Publisher
SciELO
Publication Language
English
Frequency
Periodic
Indexing & Databases
DOAJPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 77c2e172-a04a-4afb-b8ac-16707bc3e9be
Database Updated: 2026-09-30